|

Allogeneic Adenovirus-specific Cytotoxic T Lymphocytes Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Allogeneic Adenovirus-specific CTLs

Pipeline

Phase 1: 1

Top Sponsors

  • M.D. Anderson Cancer Center1

Indications

  • Immunocompromised1
  • Hematopoietic and Lymphoid Cell Neoplasm1
  • Cancer1

Houston, Texas1 trial

Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

M D Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.